scispace - formally typeset
Open AccessJournal Article

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

Reads0
Chats0
TLDR
Since intensive glucose control with metformin appears to decrease the risk of diabetes-related endpoints in overweight diabetic patients, and is associated with less weight gain and fewer hypoglycaemic attacks than are insulin and sulphonylureas, it may be the first-line pharmacological therapy of choice in these patients.
About
This article is published in The Lancet.The article was published on 1998-09-12 and is currently open access. It has received 7395 citations till now. The article focuses on the topics: Metformin & Type 2 diabetes.

read more

Citations
More filters
Journal ArticleDOI

Dental considerations for the treatment of patients with diabetes mellitus

TL;DR: The dental team can improve the metabolic control of a patient's diabetes by maintaining optimal oral health and can reduce comorbidity factors by supporting patients in tobacco-use cessation programs.
Journal ArticleDOI

Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin-associated lactic acidosis'.

TL;DR: The link between metformin and lactic acidosis may be causal, associated or coincidental as mentioned in this paper, and the authors investigated this link by studying and analysing published reports of so-called metin-associated lact acidosis.
Journal ArticleDOI

Caring for Poorly Controlled Diabetes Mellitus: A Randomized Pharmacist Intervention

TL;DR: This pharmacist intervention did not significantly improve diabetes control, but did allow for similar HbA1c control with fewer physician visits and medication appropriateness and self-reported adherence compared with usual care in individuals with poorly controlled diabetes.
Book ChapterDOI

General aspects of diabetes mellitus

TL;DR: Strong associations have been shown in observational studies suggesting poor clinical outcomes both with chronic hyperglycemia and acutely in intensive care settings, however, tight glycemic control in this setting is a contentious issue with an increased incidence of hypoglycemi and possible increase in morbidity and mortality.
Journal ArticleDOI

Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: A retrospective cohort study

TL;DR: In this study of Medicare Part D enrollees with diabetes, patients aged <65 years, women, black or Hispanic patients, and those with higher comorbidity scores were more likely to be nonadherent to medications.
References
More filters
Journal Article

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 - 
TL;DR: In this article, the effects of intensive blood-glucose control with either sulphonylurea or insulin and conventional treatment on the risk of microvascular and macrovascular complications in patients with type 2 diabetes in a randomised controlled trial were compared.
Journal Article

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease

TL;DR: Sulfonylurea, metformin, and insulin therapies were similarly effective in improving glucose control compared with a policy of diet therapy and whether any specific therapy is advantageous or disadvantageous.
Journal ArticleDOI

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

TL;DR: The ability of troglitazone to reduce insulin resistance and improves glucose tolerance in obese subjects with either impaired or normal glucose tolerance could be useful in preventing NIDDM.
Journal ArticleDOI

Biguanides and NIDDM

TL;DR: Because metformin does not cause clinical hypoglycemia, it is actually an antihyperglycemic drug that helps combat hypertriglyceridemia, and it has been ascribed some vasoprotective properties.
Journal ArticleDOI

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

TL;DR: The UK Prospective Diabetes Study is a multi-centre, prospective, randomised, intervention trial of 5100 newly-diagnosed patients with Type 2 (non-insulin-dependent) diabetes mellitus which aims to determine whether improved blood glucose control will prevent complications and reduce the associated morbidity and mortality.
Related Papers (5)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

R C Turner, +398 more
- 12 Sep 1998 -